| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Options Exercise | $88,670 | +940 | +5.4% | $94.33 | 18,508 | 23 Feb 2024 | Direct | |
| transaction | RGEN | Common Stock | Sale | $866,204 | -4,373 | -24% | $198.08 | 14,135 | 23 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Options Exercise | $0 | +940 | +31% | $0.000000 | 4,000 | 23 Feb 2024 | Common Stock | 940 | $94.33 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | $198.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.73 to $198.46 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F2 | 2,000 shares vest and become exercisable on both 4/1/2024 and 4/1/2025. |